Condition: Obesity · Type 2 Diabetes · Sponsor: Imperial College London
The purpose of this study is to assess whether the changes in gut hormones seen following Roux en Y Gastric Bypass surgery are responsible for some of the beneficial effects seen post-operatively.
This description comes directly from the study's public registry record.
Tricia Tan, MBChB MRCP · t.tan@imperial.ac.uk
Always discuss trial participation with your own doctor first.
| NIHR/Wellcome Trust Imperial CRF, Hammersmith Hospital | London, Greater London, United Kingdom | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT01945840